K-ras Inhibitors and Pancreatic Cancer-Reference-Cited by-同舟云学术

K-ras Inhibitors and Pancreatic Cancer

Published:2008 Issue: Volume: Page:601-607
ISSN:
Container-title:Pancreatic Cancer
language:
Short-container-title:

Author:

Alberts Steven R.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-0-387-69252-4_35.pdf

Reference43 articles.

1. Lowy DR, Williamson BM. 1993, Function and regulation of ras. Annu Rev Biochem 62:851–891.

2. Wittinghofer A, Scheffzek K, Ahmadian MR. 1997, The interaction of Ras with GTPase-activating proteins. FEBS Letts 410:63–67.

3. Rozenblum E, Schutte M, Goggins M, 1997, Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57:1731–1734.

4. Moskaluk CA, Hruban RH, Kern SE. 1997, p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 57:2140–2143.

5. Sakorafas GH. 1999, Pancreatic cancer. In: Kurzrock R, Talpaz M (eds.) Molecular biology in cancer medicine, 2nd ed. London, Martin Dunitz Ltd, 393–409.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives;European Journal of Medicinal Chemistry;2017-01

2. Pancreatic cancer, treatment options, and GI-4000;Human Vaccines & Immunotherapeutics;2015-04-03

3. Pancreatic cancer, treatment options, and GI-4000;Human Vaccines & Immunotherapeutics;2014-11-02

4. Investigational Biomarkers for Pancreatic Adenocarcinoma: Where Do We Stand?;Southern Medical Journal;2014-04

5. Signaling Cross-Talk of Oncogenic KRAS and Hedgehog Pathways in Pancreatic Cancer;Hedgehog signaling activation in human cancer and its clinical implications;2011